John C. Arthur
Corporate Officer/Principal at HERON THERAPEUTICS, INC.
Profile
John C.
Arthur is currently the Vice President-Manufacturing & Supply at Heron Therapeutics, Inc. He was previously the Senior Director-Manufacturing at Auspex Pharmaceuticals, Inc. and the Vice President-Manufacturing & CMC at Mast Therapeutics, Inc. Dr. Arthur holds a doctorate degree from the University of South Carolina and an undergraduate degree from Western Washington University.
John C. Arthur active positions
| Companies | Position | Start |
|---|---|---|
| HERON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
Former positions of John C. Arthur
| Companies | Position | End |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2016 |
| AUSPEX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2013 |
Training of John C. Arthur
| University of South Carolina | Doctorate Degree |
| Western Washington University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- John C. Arthur
